Imunovida Vacinas

What Imunovida Vacinas does

Imunovida Vacinas (legal name: IMUNOVIDA CLÍNICA DE VACINAS LTDA) is a privately held vaccination clinic headquartered in Uberlândia, Minas Gerais, Brazil. Founded in 2012 by nurse Gizele Maciel under the original name Mais Saúde Clínica de Vacinas and rebranded to Imunovida in 2016, the company operates two physical locations in Uberlândia — the Matriz headquarters in Centro (inaugurated in 2021) and a unit inside the Uberlândia Medical Center (UMC) complex (opened in 2018). Cumulative scale to date includes over 850,000 vaccinations administered, more than 1 million patient attendances, and over 500,000 corporate vaccinations across 11 years of operations.

The clinic's product surface is a portfolio of 20+ vaccines organized by life stage (newborns, children, adolescents, adults, elderly, pregnant women, occupational), following SBIm (Brazilian Society of Immunizations) and Ministry of Health (PNI) guidelines. Key offerings include age-segmented vaccination plans, home-visit immunization (Imunovida Até Você), corporate on-site vaccination programs (Vacinação Corporativa), and recently introduced vaccines such as Pneumo 20 (2024), Abrysvo for pregnant women (2025), and the dengue vaccine (2025). The business model is fee-for-service professional services delivered either to individual patients (walk-in, appointment, or home visit) or to corporate clients (on-site workplace campaigns). Customer acquisition runs through organic social media (Instagram, Facebook, LinkedIn, TikTok, YouTube, Pinterest), a content blog, and direct contact via WhatsApp and phone.

Revenue is not publicly disclosed. The company is a founder-owned Brazilian LTDA (limited liability company) with no external funding, no parent company, no subsidiaries, and approximately 10 employees. All operations are concentrated in the Uberlândia/Triângulo Mineiro region of Brazil, with no international footprint. Distribution is multi-channel (retail clinic, home visit, direct corporate sales) but geographically narrow.

Name

Imunovida Vacinas

Legal name

IMUNOVIDA CLÍNICA DE VACINAS LTDA

Website

https://imunovidavacinas.com.br

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

1–10 employees

Short description

Imunovida Vacinas is a privately held, founder-owned vaccination clinic in Uberlândia, Brazil, offering 20+ vaccines across all age groups via two physical clinics, a home-visit service, and on-site corporate vaccination programs for businesses.

Ownership category

akta.pro rank

Product category

Vaccination & Immunization Services

NAICS

Offices of All Other Miscellaneous Health Practitioners (621399), Other Ambulatory Health Care Services (6219), Offices of Physicians (62111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Misc Health & Allied Services, Nec (8090)

akta.pro industry

PRIMARYHLAJAHAB

Public & Private Vaccine Provider Networks (Clinics/Pharmacies/Physicians)

Healthcare & Life Sciences/Public Health, Government & Regulators/Immunization Programs & Vaccine Administration

SECONDARYHLAKAGAJ

Immunization & Vaccine Clinics

Healthcare & Life Sciences/Specialist Medical Practice/Infectious Disease

SECONDARYHLAJAHAI

Travel, Occupational & Special-Population Vaccination Programs

Healthcare & Life Sciences/Public Health, Government & Regulators/Immunization Programs & Vaccine Administration

Keywords

• Vaccination clinic services
• Immunization services
• Corporate vaccination programs
• Home vaccination services
• Pediatric and adult vaccines

Headquarters

HQ city

Uberlândia

HQ country

Brazil

HQ region

Latin America

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Vaccination Services: Direct vaccination services to individuals and families across all age groups (newborns, children, adolescents, adults, elderly). Services include personalized vaccination plans and at-home care.
2. Corporate Vaccination Programs: Workplace vaccination campaigns for businesses, providing vaccination services to employees with customizable corporate plans and health prevention programs.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels8 records

Core offering

Imunovida Vacinas is a private vaccination clinic that administers immunizations to individuals across all age groups (newborns, children, adolescents, adults, elderly) following SBIm and PNI guidelines, operating through two physical units in Uberlândia. It complements in-clinic services with a home-visit vaccination program (Imunovida Até Você) and corporate on-site workplace vaccination campaigns designed to reduce absenteeism. The portfolio includes more than 20 vaccines, including dengue, HPV, influenza, COVID-19, pneumococcal, hepatitis, meningococcal, herpes zoster, and RSV vaccines.

Product overview

Imunovida Vacinas is a vaccination clinic offering a comprehensive portfolio of immunization services organized by age group (newborns, children, adolescents, adults, elderly). The portfolio includes more than 20 vaccines from birth through elderly age, covering vaccines for Covid-19, dengue, HPV, influenza, pneumococcal disease, hepatitis, meningococcal disease, herpes zoster, RSV (Arexvy, Abrysvo, Beyfortus), and others. Services include in-clinic vaccination, corporate vaccination programs for businesses, and home-based care (Imunovida Até Você). The company operates two physical units in Uberlândia, Brazil and provides vaccination calendars following SBIm guidelines.

Differentiator

Problem solved

Functional benefit

Products and services

• Age-Based Vaccination Services (Newborns, Children, Adolescents, Adults, Elderly) Comprehensive immunization services for individuals from newborns to seniors, organized into age-specific vaccination calendars aligned with SBIm (Brazilian Society of Immunizations) recommendations and PNI guidelines. Covers premature infants through seniors 60+, including the Calendário de Vacinação offering.
• Corporate Vaccination Program (Vacinação Corporativa) On-site workplace vaccination campaigns for businesses and organizations, providing customizable corporate plans, on-site employee immunization, and health prevention programs positioned to reduce absenteeism (cited 42% reduction, JAMA) and influenza cases (25–40% fewer). Includes more than 500,000 corporate vaccinations administered historically.
• Imunovida Até Você (Home Visit Vaccination Service) Personalized at-home vaccination service for patients unable to visit the clinic, offering convenient immunization with the clinic's qualified nursing team.
• Dengue Vaccine (Vacina contra a Dengue) Dengue vaccine made available to the general population at Imunovida's clinics and via home visits.
• Abrysvo (RSV Vaccine for Pregnant Women) RSV (respiratory syncytial virus) vaccine indicated for pregnant women (24th–36th week) to protect newborns, and for adults aged 18–59 with increased risk factors.
• Vacina Pneumo 20 (Pneumococcal 20-valent Vaccine) Pneumococcal 20-valent vaccine providing enhanced protection against pneumococcal diseases (pneumonia, meningitis, septicemia), available at Imunovida clinics.

Quantifiable outcome

• 42% reduction in work absences with corporate vaccination programs (per Journal of American Medical Association study)
• +2 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Others

• Instituto Butantan: Brazil's primary public vaccine producer and one of the main suppliers to the Ministry of Health's PNI program. Relevant as a comparator for the vaccine ecosystem even though it operates as a public manufacturer rather than a private clinic.
• Dasa: Brazil's largest medical diagnostics company. While not a direct vaccination competitor, it is a comparable healthcare service provider in Brazil with a multi-site clinical footprint and adjacent preventive health services.
• Fundação Oswaldo Cruz (Fiocruz): Brazilian public health foundation and major vaccine manufacturer supplying the SUS/PNI immunization program. Comparable as a counterparty in the Brazilian vaccination ecosystem, defining the public-sector alternative to private clinics like Imunovida.
• Hapvida NotreDame Intermédica: Large Brazilian healthcare operator combining health insurance with owned clinics and hospitals. Comparable as a vertically integrated healthcare provider offering preventive services including immunization to its member base.
• Rede D'Or: Brazil's largest hospital and diagnostic network. Comparable as a major private healthcare provider in Brazil with robust outpatient and preventive care offerings, though focused on hospital-based services.
• Hermes Pardini: Brazilian medical diagnostics company acquired by Dasa. Comparable as a clinical services provider in the preventive healthcare segment, though focused on diagnostic testing rather than vaccination delivery.

Direct peers

• Dr. Consulta: Brazilian chain of outpatient clinics offering affordable healthcare services including vaccinations, consultations, and preventive care. Directly comparable as a multi-location outpatient clinic serving similar retail consumer segments.

Broad incumbents

• Drogaria São Paulo (DPSP): Large São Paulo-based pharmacy chain (now part of RD Saúde) with strong vaccination services and a broad footprint. Comparable as a retail-channel vaccination provider with similar product breadth but a much larger geographic reach.
• Pague Menos: Major Brazilian pharmacy chain with 1,600+ stores across regions including Minas Gerais. Provides walk-in vaccination services in many locations, directly competing with independent clinics for retail vaccination demand.
• RD Saúde (Raia Drogasil): Brazil's largest pharmacy chain, formed via merger of Drogaria São Paulo, Drogaria Pacheco, and Raia. Offers in-store vaccination services across a national footprint of 2,800+ stores, representing the most significant scale competitor for retail vaccination volumes.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/IVacinas
• YouTubeyoutube.com/channel/UCMuEk_Q8IC5iIn8FF9lRZlQ
• Facebookfacebook.com/imunovidauberlandia
• LinkedInlinkedin.com/company/imunovida-vacinas
• Instagraminstagram.com/imunovidavacinas
• TikToktiktok.com/@imunovidavacinas
• Pinterestbr.pinterest.com/imunovidavacinas

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Imunovida Vacinas